Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Fesoterodine

Fesoterodine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Fesoterodine

23 trials tracked of Fesoterodine: 14 in phase 3 or 4 and 1 with published results. The most-cited published study has 5 citations.

23Trials tracked
14Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 7 Phase 3 7 Phase 2 3 Phase 1 1 Other / NA 5
  1. Phase 4 Fall Prevention in Older Adults With OAB Completed · 5 cited
  2. Phase 4 Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder Completed
  3. Phase 4 UK Study Assessing Flexible Dose Fesoterodine in Adults Completed
  4. Phase 4 A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency Completed
  5. Phase 4 Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) Completed
  6. Phase 4 A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder Completed
Show 17 more trials
  1. Phase 4 A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. Completed
  2. Phase 3 Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) Completed
  3. Phase 3 Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. Completed
  4. Phase 3 Fesoterodine Flexible Dose Study Completed
  5. Phase 3 A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients Completed
  6. Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) Completed
  7. Phase 3 Fesoterodine "add-on" Male Overactive Bladder Study Completed
  8. Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. Completed
  9. Phase 2 Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years Completed
  10. Phase 2 Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients Completed
  11. Phase 2 Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. Completed
  12. Phase 1 This Is A Study Of Bioavailability And Food Effect For Fesoterodine. Completed
  13. N/A Drug Use Investigation for Toviaz Completed
  14. N/A Comparative Urine Proteomic Studies of Overactive Bladder in Humans Completed
  15. N/A This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder Completed
  16. N/A Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder Completed
  17. N/A Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy Completed

Showing the 23 most-cited and recently-updated of 23 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.